- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07767734
Comparison of the BOPPPS Model and Traditional Instructional Method in Medicinal Chemistry Education
11 agosto 2026 aggiornato da: Liang Qi, Jiangsu Medical College
Comparison of the BOPPPS Model and Traditional Instructional Method in Medicinal Chemistry Education for Pharmacy Students
This study aims to compare the teaching effect of the BOPPPS teaching model and the traditional lecture-based teaching method in Medicinal Chemistry courses for pharmacy students.
Two groups of students receiving different teaching strategies will be included in this retrospective controlled study.
The primary evaluation indicators include students' final examination scores, and secondary indicators cover classroom learning engagement and student satisfaction questionnaires.
The overall objective is to explore whether the BOPPPS model can improve students' learning performance and learning experience in Medicinal Chemistry teaching.
No human clinical intervention or invasive testing is involved in this educational research.
Panoramica dello studio
Stato
Completato
Intervento / Trattamento
Descrizione dettagliata
This educational controlled study focuses on the teaching reform of Medicinal Chemistry, a core compulsory course for pharmacy majors in higher vocational colleges.
Traditional lecture-centered teaching is widely adopted in vocational pharmacy teaching, which often leads to insufficient student participation, weak initiative in classroom interaction, and unsatisfactory learning efficiency for complex pharmaceutical chemical structures and synthetic reactions.The BOPPPS teaching model divides each class into six standardized links: Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment, Summary.
This student-centered teaching design strengthens classroom interaction and targeted detection of learning effects.
At present, there is limited comparative research on the application of this model in Medicinal Chemistry teaching for vocational pharmacy students.This retrospective controlled research collects historical teaching data of two student groups receiving different teaching modes.
The research intends to systematically analyze the differences in learning outcomes between the two teaching strategies, so as to provide practical teaching reform references for Medicinal Chemistry courses in vocational pharmacy education.
This study only adopts routine classroom teaching and anonymous questionnaire surveys, without any clinical medical intervention, blood sampling or physical examination on participants.
All student data are anonymized to protect personal privacy.
Article 32 of the Notice on Printing and Distributing the Measures for Ethical Review of Life Science and Medical Research Involving Humans, jointly issued by the National Health Commission of China, the Ministry of Education, the Ministry of Science and Technology, and the National Administration of Traditional Chinese Medicine, stipulates that "Life science and medical research involving humans that uses human information, data or biological samples may be exempt from ethical review if such research falls under the circumstances specified below, causes no physical harm to human participants, and does not involve sensitive personal information or commercial interests."
As a study focusing on teaching effectiveness, the present research qualifies for an exemption from ethical review pursuant to this provision.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
60
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
Jiangsu
-
Yancheng, Jiangsu, Cina, 224005
- Jiangsu Medical College
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
Accetta volontari sani
Sì
Descrizione
Inclusion Criteria:
- Full-time pharmacy students without previous Medicinal Chemistry learning experience
- Complete all academic assessments and anonymous questionnaire surveys
Exclusion Criteria:
- Classroom attendance rate less than 80%
- Students who are unwilling to provide relevant data for this educational study or miss the final exam
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Experimental Group (BOPPPS Teaching Model)
Pharmacy students receive Medicinal Chemistry courses adopting the complete six-link BOPPPS teaching design, including Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment and Summary.
Interactive classroom activities and in-class tests are arranged in each lesson.
|
Medicinal Chemistry teaching based on BOPPPS model, consisting of Bridge-in, Objectives, Pre-assessment, Participatory learning, Post-assessment and Summary sessions with abundant classroom interaction.
|
|
Comparatore attivo: Control Group (Traditional Lecture Teaching)
Pharmacy students receive teacher-centered traditional lecture-based Medicinal Chemistry teaching.
The teacher explains knowledge points directly, with few classroom interactive sessions.
|
Traditional teacher-centered lecture teaching for Medicinal Chemistry, mainly knowledge explanation, without segmented pre-assessment and post-assessment arrangements.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Final examination scores of Medicinal Chemistry
Lasso di tempo: At the completion of the teaching intervention, up to 1 week
|
Final exam scores to evaluate students' mastery of professional knowledge of Medicinal Chemistry.
Scores range from 0 to 100.
Higher scores indicate better academic performance.
|
At the completion of the teaching intervention, up to 1 week
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Student teaching satisfaction score
Lasso di tempo: At the completion of the teaching intervention, up to 1 week
|
Score from an anonymous questionnaire evaluating students' satisfaction with the classroom teaching model.
The total score ranges from 1 to 5. Higher scores indicate higher satisfaction.
|
At the completion of the teaching intervention, up to 1 week
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Investigatori
- Investigatore principale: Liang Qi, PhD, Jiangsu Medical College
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
15 settembre 2025
Completamento primario (Effettivo)
6 gennaio 2026
Completamento dello studio (Effettivo)
8 gennaio 2026
Date di iscrizione allo studio
Primo inviato
6 agosto 2026
Primo inviato che soddisfa i criteri di controllo qualità
11 agosto 2026
Primo Inserito (Effettivo)
17 agosto 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
17 agosto 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
11 agosto 2026
Ultimo verificato
1 agosto 2026
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- JiangsuMC-20260806
- 2025JGYB272 (Altro numero di sovvenzione/finanziamento: Jiangsu Society of Higher Education)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
SÌ
Descrizione del piano IPD
De-identified individual participant-level data supporting this study, together with a complete data dictionary, will be accessible to qualified external researchers upon reasonable written request after the primary manuscript is published.
Data release is conditional on institutional and regulatory privacy authorization.
All formal data access requests should be submitted to the corresponding author for evaluation and review.
No identifiable personal information will be included in shared datasets to protect student privacy.
Periodo di condivisione IPD
De-identified individual participant data and supporting documents will be available to qualified researchers indefinitely after the publication of the primary study manuscript.
Criteri di accesso alla condivisione IPD
Data and supporting documents are available only to qualified academic researchers with legitimate educational research objectives.
All applicants shall submit a formal written research request to the corresponding author.
Data release is subject to institutional privacy and regulatory authorization.
Applicants must provide a clear research plan and agree to use the shared de-identified data solely for independent academic research, without attempting to re-identify participants or share datasets with third parties.
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
- ICF
- CODICE_ANALITICO
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .